Jennifer Doudna
CRISPR, translational control, RNAi
CRISPR, translational control, RNAi
synthetic biology, quorum sensing, biofilm formation, cell-cell communication, directed evolution
metabolic engineering, synthetic biology, sustainable chemical production, applied microbiology, systems biology, RNA splicing, microbiology
biosensors, biomaterials, novel circuits, defense applications
metabolic pathway engineering, biofuels, biochemistry, chemical biology, synthetic biology, pharmaceuticals
genetic devices, design rules, microRNAs
science and technology studies, sociology of science, philosophy of biology, science policy, engineering studies, synthetic biology, systems biology
bioorthogonal chemistry, glycomics, biochemistry, organic synthesis, biopolymers, cell-cell communication
microbial chemistry, microbial communities, human microbiota, novel enzymes, biocompatible chemistry
directed evolution, material engineering, hybrid materials, self-assembly, electronic materials, magnetic materials
carbon capture, bio-solar energy generation, electronic materials, mineralization of carbonates, self assembly of S-layer proteins, nanostructure assembly
bioinspired materials, slippery surfaces, adaptive hybrid architectures, self-assembly, bionanointerfaces, crystal growth, nanostructured surfaces
synthetic biology, microbial ecology, art-science collaboration, science communication
Nothing to see here.
Emeryville, California
Company size: 100
Est. number of positions: 1
Heidi Ledford. Nature.
UC’s patent for its pioneering CRISPR discovery sets up a big battle over its rights. Los Angeles Times.
Jeffery M. Perkel. Nature.
Matthew Verosloff, James Chappell, Keith L. Perry, Jeremy R. Thompson, and Julius B. Lucks. ACS Synthetic Biology.